https://cyclepharma.com/news/ormalvi-launch/ 2024-05-20T08:18:33+00:00 https://cyclepharma.com/wp-content/uploads/2024/05/ORMALVI-for-news-story.png https://cyclepharma.com/news/tascenso-odt-fingolimod/ 2024-05-20T08:29:13+00:00 https://cyclepharma.com/wp-content/uploads/2024/02/tasecnso-logo-block.png https://cyclepharma.com/news/tascenso-odt-fingolimod-launch/ 2024-05-29T13:15:44+00:00 https://cyclepharma.com/wp-content/uploads/2022/06/istock-10600428601.jpg https://cyclepharma.com/news/new-us-product-javygtor-sapropterin-dihydrochloride-tablets-and-powder-launches-for-phenylketonuria-pku-treatment/ 2024-05-29T13:16:15+00:00 https://cyclepharma.com/news/new-zealand/ 2024-05-29T13:20:48+00:00 https://cyclepharma.com/wp-content/uploads/2021/03/Newzealand-PR-.png https://cyclepharma.com/news/od/ 2024-05-29T13:22:56+00:00 https://cyclepharma.com/wp-content/uploads/2020/09/2.png https://cyclepharma.com/news/dr-buckeridge/ 2024-05-29T13:23:32+00:00 https://cyclepharma.com/wp-content/uploads/2020/09/david-buckeridge-announcement-photo.png https://cyclepharma.com/news/otw/ 2024-05-29T13:24:08+00:00 https://cyclepharma.com/wp-content/uploads/2020/09/ones-to-watch.png https://cyclepharma.com/news/25m/ 2024-05-29T13:25:19+00:00 https://cyclepharma.com/wp-content/uploads/2016/06/logox2-75.png https://cyclepharma.com/news/covid-19-response/ 2024-05-29T13:25:53+00:00 https://cyclepharma.com/wp-content/uploads/2020/07/covid-icon-large-wide.png https://cyclepharma.com/wp-content/uploads/2020/07/wellbeing-logos.jpg https://cyclepharma.com/news/saudi_authorization_nityr/ 2024-05-29T13:26:24+00:00 https://cyclepharma.com/wp-content/uploads/2020/05/cycle-meca-1-1.jpg https://cyclepharma.com/news/online-meeting-series/ 2024-05-29T13:27:20+00:00 https://cyclepharma.com/wp-content/uploads/2020/04/Transparent-Background-1-1.png https://cyclepharma.com/news/supplychain/ 2024-05-29T13:27:53+00:00 https://cyclepharma.com/wp-content/uploads/2020/03/Alina_sml.jpg https://cyclepharma.com/news/nityr_in_aus/ 2024-05-29T13:29:28+00:00 https://cyclepharma.com/wp-content/uploads/2019/04/Picture1.png https://cyclepharma.com/news/nityr_in_chile/ 2024-05-29T13:30:00+00:00 https://cyclepharma.com/wp-content/uploads/2018/11/cycle-axon-e1542889002540.png https://cyclepharma.com/news/longer-shelf-life/ 2024-05-29T13:30:46+00:00 https://cyclepharma.com/wp-content/uploads/2018/11/BLUE-BACKGROUND-WITH-TABLETS-AND-BOTTLE.png https://cyclepharma.com/news/ketorolac_approval-4/ 2024-05-29T13:41:12+00:00 https://cyclepharma.com/wp-content/uploads/2018/11/Nityrcycle-logo.jpg https://cyclepharma.com/news/cycle-pharmaceuticals-receives-fda-approval-of-nityrtm-nitisinone-tablets-for-treatment-of-ht-1/ 2024-05-29T13:43:48+00:00 https://cyclepharma.com/wp-content/uploads/2017/08/iStock-670930640-R-PRESS.jpg https://cyclepharma.com/news/cycle-pharmaceuticals-the-university-of-cambridge-and-kings-college-london-partner-to-repurpose-parp-inhibitor-drugs-for-vascular-disease/ 2024-05-29T13:46:50+00:00 https://cyclepharma.com/wp-content/uploads/2016/12/press-news.3-e1482229881240.png https://cyclepharma.com/news/cycle-pharmaceuticals-launches-sajazir-tm-icatibant-injection/ 2024-05-29T14:28:38+00:00 https://cyclepharma.com/wp-content/uploads/2021/09/Sajazir-Logo-CMYK.jpg https://cyclepharma.com/news/tony-cates-joins-cycle-group-holdings-board-of-directors/ 2024-05-29T14:29:09+00:00 https://cyclepharma.com/wp-content/uploads/2021/10/Tony-e1708524627943.jpg https://cyclepharma.com/news/ms-patients-in-us-will-receive-equivalent-backing-from-cycle-pharmaceuticals-with-tascenso-odt/ 2024-05-29T14:30:12+00:00 https://cyclepharma.com/wp-content/uploads/2024/03/Boy-with-Mum.jpg https://cyclepharma.com/news/cycle-pharma-launches-cycle-vita/ 2024-05-30T15:19:58+00:00 https://cyclepharma.com/wp-content/uploads/2021/09/Cycle-Vita-logo-stacked-RGB-scaled.jpg https://cyclepharma.com/news/new-tiopronin-delayed-release-tablets-launch/ 2024-05-31T09:36:21+00:00 https://cyclepharma.com/wp-content/uploads/2024/05/Cycle-Vita-logo-for-tiopronin-product-page-and-news.png https://cyclepharma.com/news/free-goods/ 2024-06-05T15:57:22+00:00 https://cyclepharma.com/wp-content/uploads/2024/02/inceptua.png https://cyclepharma.com/news/proposal-to-acquire-vanda/ 2024-06-06T12:00:01+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/cycle-pharmaceuticals-reaffirms/ 2024-10-14T12:20:22+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/duncan-kennedy-cfo/ 2024-11-05T18:38:33+00:00 https://cyclepharma.com/wp-content/uploads/2024/11/Website_CFO-Duncan-Kennedy-post.png https://cyclepharma.com/news/cycle-pharma-acquires-banner-life-sciences-llc/ 2025-01-13T10:20:00+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/venxxiva-tiopronin-tablets-launch/ 2025-03-31T13:14:42+00:00 https://cyclepharma.com/wp-content/uploads/2025/01/couple-tile.png https://cyclepharma.com/news/cycle-vita-pku-launch/ 2025-04-23T13:58:59+00:00 https://cyclepharma.com/wp-content/uploads/2025/04/CV-PKU-1.png https://cyclepharma.com/news/bafiertam-monomethyl-fumarate-capsules/ 2025-04-23T14:03:36+00:00 https://cyclepharma.com/wp-content/uploads/2025/04/Bafiertam-Image.png https://cyclepharma.com/news/first-fda-approved-treatment-for-aku/ 2025-07-16T17:19:57+00:00 https://cyclepharma.com/wp-content/uploads/2025/05/harliku.png https://cyclepharma.com/news/harliku-nitisinone-tablets-launch/ 2025-07-17T12:53:32+00:00 https://cyclepharma.com/wp-content/uploads/2025/07/HARLIKU-3.png https://cyclepharma.com/news/exclusive-us-sales-license-phyrago-dasatinib-tablets/ 2025-07-21T13:03:45+00:00 https://cyclepharma.com/wp-content/uploads/2025/07/PHYRAGO-3.png https://cyclepharma.com/news/phyrago-dasatinib-tablets-launch/ 2025-12-11T11:06:26+00:00 https://cyclepharma.com/wp-content/uploads/2025/07/PHYRAGO-3.png https://cyclepharma.com/news/extension-of-applied-therapeutics-tender-offer/ 2026-01-28T15:00:32+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/further-extension-of-applied-therapeutics-tender-offer/ 2026-01-29T13:09:37+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/extension-of-applied-therapeutics-tender-offer-3/ 2026-01-30T13:00:01+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/acquisition-of-applied-therapeutics/ 2026-02-03T14:22:16+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/cavhanza-nilotinib-orally-disintegrating-tablets-fda-approval/ 2026-06-11T13:57:42+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg https://cyclepharma.com/news/cavhanza-nilotinib-orally-disintegrating-tablets-launch/ 2026-08-28T02:48:55+00:00 https://cyclepharma.com/wp-content/uploads/2026/08/CAVHANZA-2600002-Update-1.png https://cyclepharma.com/news/alkaptonuria-telehealth-service/ 2026-09-02T13:33:59+00:00 https://cyclepharma.com/wp-content/uploads/2024/06/cycle-pharma-press-release-1.jpg